Diagnosis to therapy: The future of image-guided patient management
SNMMI Virtual Annual Meeting to take place July 11-14
WHAT: The Society of Nuclear Medicine and Molecular Imaging 2020 Virtual Annual Meeting
Novel research on new and better ways to diagnose and treat cancers, inflammation, arthritis, chronic pain, stroke, brain disease, and more
The SNMMI Virtual Annual Meeting will convene more than 6,000 attendees (physicians, scientists, technologists and exhibitors) from around the globe to share breaking news and research in the field of nuclear medicine and molecular imaging.
The focus is on precision medicine–improving patients’ lives by developing new ways to diagnose earlier and more accurately, delivering the most effective therapy for a specific patient’s disease, and monitoring and adjusting treatment to ensure optimum results.
WHEN: July 11-14, 2020
WHERE: This is a virtual meeting utilizing an innovative, interactive platform to offer live continuing education sessions, on-demand access to hundreds of scientific abstracts, a cutting-edge exhibit hall, and networking events–all in a flexible format designed to accommodate any schedule.
For the most current meeting agenda, see the online program.
**Media must register in order to get access to the meeting.**
For media registration, please contact Rebecca Maxey, SNMMI Director of Communications, at: [email protected] or (703) 652-6772.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit http://www.